| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6169458 | The Breast | 2015 | 6 Pages |
Abstract
Compared with control, the addition of HER2 blockades may not increase the risk of FAEs among patients with breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Junyan Wu, Kaifeng Qiu, Jianhong Zhu, Jianfang Li, Yin Lin, Zhichao He, Guocheng Li,